1. Introduction {#s0005}
===============

Storage lipids in all types of eukaryotic cells accumulate mostly as triacylglycerols (TAG) and steryl esters (SE) which are the major components of a specialized globular compartment of the cell named lipid particle (LP), lipid droplet, lipid body or oil body [@bb0005]. LP consist of a randomly packed TAG core surrounded by several more or less ordered SE shells and a phospholipid surface monolayer with a small set of specific proteins embedded [@bb0005; @bb0010; @bb0015]. Mechanism(s) of LP biogenesis are still a matter of dispute [@bb0020], but the most convincing hypothesis for this process is budding of LP from the endoplasmic reticulum (ER) [@bb0010; @bb0025; @bb0030; @bb0035]. According to this model, TAG and SE formed in the ER accumulate in certain microdomains of the ER membrane. Upon further synthesis of neutral lipids, LP precursors are formed, which at a critical size bud off the ER and are released into the cytosol [@bb0010; @bb0020].

In *Saccharomyces cerevisiae* two proteins localized to the ER, Are1p and Are2p, catalyze the synthesis of SE with slightly different substrate specificity. Are2p is the major SE synthase of the yeast and prefers ergosterol as a substrate, whereas Are1p uses ergosterol and its precursors at nearly equal efficiency with a slight preference for lanosterol. Mutants lacking *ARE1* and *ARE2* are completely devoid of SE and accumulate free sterols [@bb0025; @bb0040]. In addition, Are1p and Are2p can also catalyze TAG synthesis although with minor efficiency compared to the two major yeast TAG synthesizing enzymes, Dga1p and Lro1p [@bb0040; @bb0045; @bb0050; @bb0055; @bb0060]. In *Saccharomyces cerevisiae* two primary mechanisms of TAG formation were identified, namely an acyl-CoA dependent reaction catalyzed by the diacylglycerol acyltransferase (DGAT) Dga1p, and an acyl-CoA independent pathway involving the phospholipid:diacylglycerol acyltransferase (PDAT) Lro1p [@bb0045; @bb0050; @bb0055; @bb0060; @bb0065; @bb0070]. Dga1p is dually localized to the ER and LP and appears to be more efficient than Lro1p under standard growth conditions when cells are in the stationary phase [@bb0015; @bb0045; @bb0050; @bb0055]. In contrast, Lro1p which requires phospholipids as acyl donor is exclusively localized to the ER [@bb0060; @bb0065; @bb0070; @bb0075]. Lro1p preferentially uses phosphatidylethanolamine (PE) as co-substrate *in vitro* and transfers its *sn-2* acyl group to diacylglycerol (DAG), resulting in the formation of TAG and lyso-PE [@bb0065; @bb0070; @bb0075]. This reaction has no counterpart in mammalian cells.

The link between TAG synthesis and PE metabolism through Lro1p as described above led us to investigate metabolic interactions between biosynthesis/degradation of these two lipids in some more detail. In *Saccharomyces cerevisiae*, PE synthesis occurs by four different pathways. In brief, two of these pathways are accomplished by phosphatidylserine (PS) decarboxylases Psd1p and Psd2p which use PS as a substrate. While Psd1p is localized to mitochondria, Psd2p is a component of a Golgi/vacuolar compartment [@bb0080; @bb0085; @bb0090; @bb0095; @bb0100; @bb0105]. Yeast PE can also be synthesized through the cytidyldiphosphate ethanolamine (CDP-Etn) branch of the so-called Kennedy pathway using Etn and DAG as substrates [@bb0080; @bb0110; @bb0115]. The CDP-Etn pathway is also linked to sphingolipid metabolism through the action of the dihydrosphingosine phosphate lyase Dpl1p which sets Etn-P free [@bb0120; @bb0125]. Moreover, the lyso-PE acyltransferase Ale1p which is present in the mitochondria associated ER (MAM) catalyzes an alternative pathway to form PE [@bb0130; @bb0135]. Surprisingly, Tgl3p, the major yeast TAG lipase, can also act as a lyso-PE acyltransferase [@bb0140].

In a series of studies from our laboratory [@bb0145; @bb0150; @bb0155; @bb0160; @bb0165] we observed preferences in the incorporation of newly formed PE through the different pathways into different cellular compartments. These findings led us to speculate that also distinctions regarding the relative contributions of PE biosynthesis to TAG formation by Lro1p may exist between the different PE synthesizing routes. We used haploid single and multiple deletion strains bearing defects in PE biosynthesis, namely *psd1Δ*, *psd2Δ*, *psd1Δpsd2Δ*, *cki1Δdpl1Δeki1Δ* (CDP-Etn mutant) and *ale1Δ* to address this question. Yeast cells used for these experiments were grown on the non-fermentable carbon source lactate because under these conditions the level of PE in the cell becomes more critical for cell growth and viability than in glucose grown cells [@bb0155]. Here we report a clear metabolic link between TAG formation in the yeast and PE synthesis *via* the CDP-Etn branch of the Kennedy pathway, but not by other PE biosynthetic routes. In the light of these findings, the lipid metabolic network of PE and TAG metabolism in the yeast is discussed.

2. Materials and methods {#s0010}
========================

2.1. Strains and culture conditions {#s0015}
-----------------------------------

Strains used throughout this study are listed in [Table 1](#t0005){ref-type="table"}. Cells were cultivated aerobically in 2 l Erlenmeyer flasks to the stationary growth phase (A~600~ \~ 4) at 30 °C in minimal lactate medium consisting of 2.66% lactate (Roth), 0.67% yeast nitrogen base without amino acids (USBiological), 0.073% amino acid mix (Roth, Fluka) supplemented with 5 mM Etn (Merck) and adjusted to pH 5.5 with KOH. Main cultures were inoculated to an A~600~ of 0.1 from precultures grown aerobically for 48 h in YPD medium containing 1% yeast extract (Oxoid), 2% peptone (Oxoid) and 2% glucose (Merck) at 30 °C.

For synthesis of radioactively labeled \[^14^C\]phospholipids, a *dga1Δlro1Δ* double deletion strain was grown on minimal glucose media containing 2% glucose (Merck), 0.67% yeast nitrogen base without amino acids (USBiological) and 0.073% amino acid mix (Roth, Fluka). Details of the labeling procedure will be described below.

2.2. Strain construction {#s0020}
------------------------

Single-step deletion of chromosomal genes was carried out using the PCR-mediated technique described by Longtine et al. [@bb0170]. The marker module His3MX6 including the *Schizosaccharomyces pombe his5*^*+*^ gene on the vector pFA6a was used to replace *YNL169c* encoding Psd1p and *YOR245c* encoding Dga1p in the single deletion strains *psd2Δ::KanMX4* and *lro1Δ::KanMX4*, respectively [@bb0170; @bb0175; @bb0180]. Deletion cassettes containing homologous regions to start and stop regions of either *PSD1* or *DGA1* and the entire *HIS5*^*+*^ gene were constructed with primers listed in [Table 2](#t0010){ref-type="table"}. A 1.4 kbp PCR fragment was generated with *ExTaq* DNA polymerase (Takara, Otsu, Japan) by using 150 ng of plasmid as a template in a standard PCR mixture containing PCR buffer (20 mM Mg^2+^), 0.2 mM deoxynucleoside triphosphates, each, and a 1 μM solution of primers in a total volume of 100 μl. After a denaturation step of 2 min at 94 °C, fragments were amplified for 10 cycles of 15 s at 94 °C, 60 s at 55 °C, and 100 s at 72 °C; and for 25 cycles of 15 s at 94 °C, 90 s at 68 °C, and 60 s at 72 °C, followed by a final elongation step for 10 min at 72 °C.

Overnight cultures (A~600~ \~ 0.8) of single mutants *psd2Δ::KanMX4* and *lro1Δ::KanMX4* were used for transformation with the high-efficiency lithium acetate transformation method [@bb0185]. Transformants were grown on plates lacking histidine for 3 days at 30 °C. Plates used for cultivation of *psd1Δpsd2Δ* transformants contained in addition 5 mM Etn to permit growth. Large colonies were transferred to fresh plates for further selection. Clones yielding colonies were considered as positive transformants and further checked for correct integration of the respective deletion cassette. Verification of the correct replacement of *PSD1* and *DGA1* by the His3MX6 module was done by colony PCR. In brief, oligonucleotides were designed to bind outside the target locus and within the marker module [@bb0180; @bb0190]. Correct integration of the marker resulted in the appearance of the respective PCR fragment.

2.3. Isolation and characterization of subcellular fractions {#s0025}
------------------------------------------------------------

Total cell-free homogenate (3000 × *g* supernatant) and 100,000 × *g* microsomes were prepared from cells grown to the stationary growth phase as described previously [@bb0105; @bb0195]. Proteins from isolated fractions were precipitated with trichloroacetic acid at a final concentration of 10%, the obtained protein pellet was solubilized in 0.1% SDS, 0.1 M NaOH, and proteins were quantified by the method of Lowry et al. [@bb0200] with bovine serum albumin as a standard. SDS-polyacrylamide gel electrophoresis was carried out by the method of Laemmli [@bb0205], and Western blot analysis by the method of Haid and Suissa [@bb0210]. Proteins were detected by enzyme-linked immunosorbent assay using rabbit antisera as the first antibody and peroxidase-conjugated goat anti-rabbit IgG as the second antibody. Antibodies used in this study were directed against the mitochondrial and microsomal marker proteins, Por1p and 40-kDa protein, respectively [@bb0105].

2.4. Lipid extraction and analysis {#s0030}
----------------------------------

Lipids were extracted from total cell-free homogenate and microsomes of yeast cells grown to the stationary growth phase by the procedure of Folch et al. [@bb0215] using chloroform/methanol (2:1; v/v). After washing the organic phase with 0.034% MgCl~2~ solution (w/v), 2 N KCl/methanol (4:1; v/v), and methanol/water/chloroform (48:47:3; per vol), extracts were taken to dryness, dissolved in 50 μl chloroform/methanol (2:1; v/v) and applied to thin-layer chromatography (TLC) plates (Silica gel 60; Merck, Darmstadt, Germany) with the aid of a sample applicator (CAMAG, Automatic TLC Sampler 4, Muttenz, Switzerland). For analyzing neutral lipids, TAG and SE, chromatograms were developed in an ascending manner to the half-distance of the plate by using light petroleum/diethyl ether/acetic acid (70:30:2; per vol). After brief drying, TLC were further developed to the top of the plate using light petroleum/diethyl ether (49:1; v/v) as the second solvent system. For separating DAG from ergosterol light petroleum/diethyl ether/acetic acid (70:10:2; per vol) were used as a solvent system and chromatograms were developed to the top of the plate. Quantification of ergosteryl esters was accomplished by densitometric scanning at 275 nm using a Shimadzu CS-930 dual-wavelength chromatoscanner and ergosterol (Sigma) as a standard. TAG were visualized by post-chromatographic staining after dipping TLC plates into a solution containing 0.8 g MnCl~2~ × 4H~2~O, 120 ml water, 120 ml methanol and 9 ml concentrated sulfuric acid, and charring at 105 °C for 30 min. Quantification of TAG was carried out by densitometric scanning at 400 nm with triolein (NuCheck, Inc., Elysian, Maine) as a standard. For analyzing total phospholipids, the same solvent systems as described above were used to separate phospholipids from neutral lipids. Lipids were visualized by iodine vapor; phospholipids were scraped off the plate and quantified by the method of Broekhuyse [@bb0220].

Individual phospholipids were separated by two-dimensional thin-layer chromatography on silica gel 60 plates (Merck) using chloroform/methanol/25% NH~3~ (68:35:5; per vol) as the first and chloroform/acetone/methanol/acetic acid/water (53:20:10:10:5; per vol) as the second developing solvent system. Phospholipids were visualized by staining with iodine vapor, scraped off the plate and quantified by the method of Broekhuyse [@bb0220].

2.5. Preparation of radiolabeled lipid substrates and measurement of TAG synthase activity *in vitro* {#s0035}
-----------------------------------------------------------------------------------------------------

Radioactively labeled \[^14^C\]phospholipids were synthesized by incubating *dga1Δlro1Δ* yeast mutants with 10 μCi \[^14^C\]oleic acid (PerkinElmer Life Sciences) for 24 h at 30 °C in 100 ml minimal glucose media (see above). After harvesting and disrupting cells with glass beads (Sartorius, 0.25--0.30 diameter), lipids were extracted and total phospholipids were separated from neutral lipids as described above. Phospholipids were scraped off the plate and extracted from the silica gel with chloroform/methanol (1:4; v/v) for 3 h. The organic phase was collected and the remaining silica gel was again extracted twice for 1 h, each. After combining the organic phases and drying under a steam of nitrogen, phospholipids were dissolved in 1 ml chloroform/methanol (2:1; v/v), and radioactivity was measured by liquid scintillation counting using LSC Safety (Baker, Deventer, The Netherlands) with 5% water as a scintillation cocktail [@bb0055]. Additionally, phospholipid concentration was quantified by the method of Broekhuyse [@bb0220].

The phospholipid:diacylglycerol acyltransferase (PDAT) assay was performed in a final volume of 200 μl containing phospholipids labeled with \[^14^C\]oleic acid (27 nmol; 70,000 dpm), 200 μg protein from 100,000 × *g* microsomes, 150 mM TrisCl (pH 7.0), 15 mM KCl, 15 mM MgCl~2~, 0.5 mM CHAPS, and 0.05 mM dioleoylglycerol [@bb0015; @bb0065]. The acyl-CoA:diacylglycerol acyltransferase (DGAT) assay was performed in a final volume of 200 μl containing 16 nmol unlabeled oleoyl-CoA and 0.68 nmol \[^14^C\]oleoyl-CoA (0.02 μCi), 100 μg protein from cell-free homogenate, 150 mM TrisCl (pH 7.0), 15 mM KCl, 15 mM MgCl~2~, 0.5 mM CHAPS, and 0.025 mM dioleoylglycerol [@bb0015; @bb0055]. Incubations were carried out for 30 min at 30 °C and terminated by addition of 3 ml chloroform/methanol (2:1; v/v). Lipids were extracted and neutral lipids were separated as described above. After visualization with iodine vapor, TAG were scraped off, and radioactivity was measured by liquid scintillation counting using LSC Safety (Baker, Deventer, The Netherlands) with 5% water as a scintillation cocktail.

2.6. RNA isolation and reverse transcription polymerase chain reaction (RT-PCR) {#s0040}
-------------------------------------------------------------------------------

Total RNA from cultivated cells grown to A~600~ \~ 2 on minimal lactate media supplemented with 5 mM Etn at 30 °C was isolated by RNeasy kit (Qiagen). Reverse transcription was carried out with 2 μg of RNA after DNAse-I treatment (1 U RQ1, Promega) in a total volume of 15 μl reverse transcription buffer (15 min at 37 °C). Reverse transcriptase from Invitrogen was used, according to the manufacturer\'s protocol. Amplification of the PCR products was measured during exponential phase of the reaction. PCR was carried out in a final volume of 30 μl containing 3 μl 10× GC buffer (BioTherm), 2 μl cDNA, 0.1 mM dNTP-Mix, 0.5 pM of each primer ([Table 2](#t0010){ref-type="table"}) and 0.6 U Polymerase (BioTherm, GenXpress). For *DGA1* expression, a fragment was obtained according to the following program. After a denaturation step of 2 min at 96 °C, fragments were amplified for 27 cycles of 5 s at 96 °C, 10 s at 55 °C, 15 s at 72 °C, a final elongation step for 10 min at 72 °C followed by cooling to 4 °C. For *LRO1* expression, the amplification was carried out for 28 cycles of 5 s at 96 °C, 10 s at 52 °C, and 15 s at 72 °C. As a control, the *ACT1* expression was tested by amplifying the fragments for 25 cycles of 10 s at 96 °C, 60 s at 58 °C and 120 s at 72 °C.

3. Results {#s0045}
==========

3.1. Growth of strains bearing defects in phosphatidylethanolamine synthesis {#s0050}
----------------------------------------------------------------------------

PE is one of the most prominent phospholipids found in yeast membranes. Previous work from our laboratory has shown that the requirement for PE in *Saccharomyces cerevisiae* is more stringent on non-fermentable carbon sources, *i.e.* when mitochondria are fully developed, than on fermentable carbon sources [@bb0155; @bb0225]. Mutants defective in either one of the PS decarboxylases, Psd1p or Psd2p, grow on glucose-containing media like wild type, but lack of both enzymes leads to auxotrophy for Etn ([Fig. 1](#f0005){ref-type="fig"}) or choline [@bb0155]. In contrast, strains with the *psd1Δ* mutation alone or in combination with *psd2Δ* are not viable on lactate as a carbon source unless rescued by addition of 5 mM Etn to the medium as a minimum requirement for viability. Lethality of *psd1Δ* on non-fermentable carbon sources is also prevented by supply with either serine or choline [@bb0155].

The requirement of a defined PE level for yeast growth and viability raised the questions whether (i) the cellular amount/availability of PE and (ii) different routes for PE biosynthesis affect TAG formation by Lro1p. For this purpose, various strains bearing defects in PE formation, in particular *psd1Δ*, *psd2Δ*, *psd1Δpsd2Δ*, *ale1Δ*, and the CDP-Etn pathway mutant *cki1Δdpl1Δeki1Δ*, were grown on minimal lactate media supplemented with Etn creating stringent conditions for PE requirement. For blocking the CDP-Etn branch of the Kennedy pathway efficiently a *cki1Δdpl1Δeki1Δ* triple mutant was required. *CKI1* and *EKI1* encode kinases with overlapping specificities for the substrates Etn and choline. Furthermore, the CDP-Etn pathway is linked to sphingolipid catabolism through the action of the dihydrosphingosine phosphate lyase Dpl1p which cleaves phosphorylated sphingoid bases to long chain aldehydes and ethanolamine phosphate (Etn-P) [@bb0120; @bb0125; @bb0155]. In addition, two mutants defective in TAG biosynthesis, *lro1Δ* and *dga1Δ*, were used to investigate TAG and phospholipid biosynthesis under these growth conditions. As expected, growth of strains defective in *PSD1* showed the longest lag phase compared to the other mutants. Nevertheless, wild type and mutants reached nearly the same A~600~ values (3--5 units) by entering the stationary growth phase (data not shown). Since neutral lipid accumulation starts at the end of exponential growth phase and reaches its highest level in the stationary phase [@bb0015], wild type and mutant cells were analyzed at this growth stage.

3.2. Neutral lipids from mutants bearing defects in phosphatidylethanolamine or triacylglycerol synthesis {#s0055}
---------------------------------------------------------------------------------------------------------

To address the question as to the link between the different PE biosynthetic routes and neutral lipid storage in the yeast, we first quantified TAG and ergosteryl esters in wild type and mutant cells grown on minimal lactate media supplemented with Etn. Previous studies had shown that in cells grown on glucose Dga1p and Lro1p contributed differentially to TAG biosynthesis with Dga1p being the more efficient enzyme [@bb0015; @bb0045]. In lactate grown cells, deletion of *DGA1* led to a reduction of the TAG content to \~ 60%, whereas deletion of *LRO1* reduced the TAG level to \~ 80% of wild type ([Fig. 2](#f0010){ref-type="fig"}). Previously, it was reported that in cells grown on glucose TAG was also synthesized by the two steryl ester synthases, Are1p and Are2p, although with minor efficiency [@bb0045; @bb0050]. In our experiments with yeast cells grown on lactate, TAG was below the detection limit in a *dga1Δlro1Δ* double deletion strain indicating that Are1p and Are2p did not contribute to TAG formation.

Deletions of *PSD1*, *PSD2*, *PSD1PSD2* and *ALE1* had no significant effect on TAG biosynthesis ([Fig. 2](#f0010){ref-type="fig"}). In contrast, a *cki1Δdpl1Δeki1Δ* strain bearing defects in the CDP-Etn branch of the Kennedy pathway exhibited a significant reduction of the TAG level to \~ 40% of wild type. This decrease was even more pronounced than in *dga1Δ* where a reduction to \~ 60% was observed. The striking observation that deletion of *LRO1* has less impact on TAG formation than a block in the CDP-Etn pathway can be explained by the compensatory effect of Dga1p. It has been shown that Dga1p is able to restore wild type TAG level in the *lro1Δ* mutant [@bb0045]. When the CDP-Etn pathway is blocked, both TAG biosynthetic routes are active but the availability of PE for Lro1p appears to become paramount and causes the observed decrease of TAG. To prove the hypothesis that the CDP-Etn pathway actively supports TAG formation in yeast, we grew wild type cells on minimal lactate media with or without supplementation of 5 mM Etn. In non-supplemented cultures the TAG level decreased to \~ 60% (38 ± 4 μg TAG/mg protein) of the control cultures supplemented with 5 mM Etn (64 ± 9 μg TAG/mg protein). These data strongly support the view that PE synthesis through the CDP-Etn pathway and TAG biosynthesis by Lro1p are linked metabolic processes.

Ergosteryl ester formation was not affected in mutants devoid of PS decarboxylases. Deletion of *LRO1*, *ALE1* or the genes of the CDP-Etn pathway led to a slight decreased ergosteryl ester level compared to wild type (see [Fig. 2](#f0010){ref-type="fig"}). Analysis of DAG levels in wild type and corresponding mutant strains revealed no changes (data not shown).

We concluded from these results that PE biosynthesis through the CDP-Etn pathway and TAG formation were tightly linked and specific. While in *cki1Δdpl1Δeki1Δ* accumulation of diacylglycerol (DAG) not used as a substrate for PE/PC formation through the Kennedy pathway was not detected and TAG formation was not enhanced, we hypothesized that the reduced level of PE as a donor of fatty acids might have a negative impact on Lro1p catalyzed TAG synthesis. Alternatively, gene regulatory effects could not be ruled out. Therefore, we considered both the availability of PE for channeling fatty acids to the acyl-CoA independent pathway of TAG synthesis and transcriptional control as possible reasons for the decreased amount of TAG in *cki1Δdpl1Δeki1Δ*.

3.3. Acyl-CoA dependent and acyl-CoA independent triacylglycerol synthase activities in mutants bearing defects in phosphatidylethanolamine synthesis {#s0060}
-----------------------------------------------------------------------------------------------------------------------------------------------------

First, we investigated the activities of TAG synthesizing enzymes in mutants compromised in PE biosynthesis. Samples of cell-free homogenate and microsomes were used to analyze acyl-CoA dependent Dga1p and acyl-CoA independent Lro1p activities, respectively. Deletion of *PSD2* in *psd2Δ* and *psd1Δpsd2Δ* strains led to 10--20% increase, whereas blocking the CDP-Etn pathway resulted in a slightly decreased Dga1p activity to \~ 80% of wild type ([Fig. 3](#f0015){ref-type="fig"}). A significant reduction of Dga1p activity to \~ 80% of wild type was only found in *psd1Δ*. Notably, Dga1p activities in *ale1Δ* and *lro1Δ* were not significantly altered.

Lro1p activity was slightly reduced in *psd1Δ* and *psd1Δpsd2Δ* and largely unaffected in *psd2Δ*, *ale1Δ* and *dga1Δ* ([Fig. 3](#f0015){ref-type="fig"}). However, a significant decrease of Lro1p activity to \~ 50% of wild type was observed in the *cki1Δdpl1Δeki1Δ* triple mutant. Although we have to take into account that enzyme activities measured *in vitro* need not always reflect the potential of an enzyme *in vivo*, we can speculate that reduced activity of Lro1p in *cki1Δdpl1Δeki1Δ* may contribute to the lower TAG content of this strain.

3.4. LRO1 and DGA1 gene expression in mutants bearing defects in phosphatidylethanolamine synthesis {#s0065}
---------------------------------------------------------------------------------------------------

One explanation for the decreased TAG levels (see [Fig. 2](#f0010){ref-type="fig"}) in *cki1Δdpl1Δeki1Δ* may be reduced expression of *DGA1* and/or *LRO1*. Reverse transcription polymerase chain reaction (RT-PCR) was used to analyze the expression levels of these two genes in mutants defective in PE biosynthesis. As can be seen from [Fig. 4](#f0020){ref-type="fig"}, expression of *LRO1* was not affected in all mutants tested. This result was surprising insofar as Lro1p activity was reduced in *cki1Δdpl1Δeki1Δ* (see [Fig. 3](#f0015){ref-type="fig"}). It has to be taken into account, however, that the activity of this enzyme may be reduced by different effects, *e.g.*, by translational control, post-translational modification or enzyme inhibition. In contrast, expression of *DGA1* was dramatically down-regulated in *psd1Δ* and *psd1Δpsd2Δ* ([Fig. 4](#f0020){ref-type="fig"}). Interestingly, in both strains devoid of *PSD1*, the enzymatic activity of acyl-CoA dependent TAG formation was only slightly reduced or even increased (see [Fig. 3](#f0015){ref-type="fig"}), and TAG levels were similar to wild type (see [Fig. 2](#f0010){ref-type="fig"}). Altogether, these results indicate that transcriptional control of TAG synthesizing enzymes appears to have a minor impact, if any, on TAG formation *in vivo* and does not explain the low level of TAG in *cki1Δdpl1Δeki1Δ*. Therefore, we tested the effect of subcellular availability of the PDAT substrate PE for TAG synthesis as a possible alternative reason for our findings.

3.5. Phospholipid pattern in mutants with defects in phosphatidylethanolamine synthesis {#s0070}
---------------------------------------------------------------------------------------

Previous studies from our laboratory had shown that yeast cells require more PE on non-fermentable carbon sources than on fermentable carbon sources, and mitochondrial synthesis of PE by Psd1p becomes paramount [@bb0155]. Furthermore, it was concluded that the microsomal PE pool is mainly derived from the CDP-Etn branch of the Kennedy pathway whereas PE formed through Psd2p is preferentially metabolized to PC [@bb0145]. Here, we analyzed the cellular and microsomal PE levels of mutants defective in PE biosynthesis when yeast cells were grown on the non-fermentable carbon source lactate. Microsomal fractions were checked for purity by Western Blot (data not shown). Quality of subcellular fractions from all strains tested was identical. Phospholipid analysis revealed a reduction of the cellular PE content in *psd1Δ* and *psd2Δ*, and even more pronounced in *psd1Δpsd2Δ* as an additive effect ([Table 3](#t0015){ref-type="table"}). Notably, the cellular PE level in *cki1Δdpl1Δeki1Δ* was reduced to 17% of total phospholipids compared to 15% in *psd1Δpsd2Δ* and 25% in wild type indicating that the CDP-Etn pathway, besides Psd1p, is also an important route for cellular PE formation under these conditions. Analysis of microsomal PE levels from mutants compromised in PE biosynthesis highlighted the importance of the CDP-Etn pathway for the supply of PE to TAG synthesis by Lro1p. The microsomal PE level in *cki1Δdpl1Δeki1Δ* was dramatically reduced to 12% of total phospholipids compared to 21% in wild type and was even lower than in *psd1Δpsd2Δ* (16%), whereas deletion of either *PSD1* or *PSD2* alone had hardly any effect ([Table 3](#t0015){ref-type="table"}). The decrease in cellular and microsomal PE was mainly compensated by elevated levels of PC. Interestingly, an increased level of cellular PE was found in *ale1Δ*, whereas the microsomal level of PE was similar to wild type. Since Ale1p had been identified as an efficient lyso-PE acyltransferase [@bb0130; @bb0135] we rather expected a decrease of PE in the deletion strain. The reason for this finding may be that Ale1p has a broad substrate specificity [@bb0230; @bb0235; @bb0240] and/or other PE forming enzymes might compensate for the deletion of *ALE1*.

The total cellular amounts of phospholipids ([Fig. 5](#f0025){ref-type="fig"}) remained nearly constant in all PE mutants and comparable to wild type. However, the cellular level of total phospholipids was significantly increased in *dga1Δlro1Δ*. This result can be explained by the utilization of DAG which is not converted to TAG in this strain *via* CDP-Etn pathway for phospholipid synthesis.

4. Discussion {#s0075}
=============

Here, we report a novel physiological link between phospholipid metabolism and TAG formation in the yeast *Saccharomyces cerevisiae*. At first sight, this finding appears to be not surprising, because both lipid classes recruit their DAG moiety from the same precursor phosphatidic acid. During exponential growth of the yeast, these precursors are rather channeled to phospholipid synthesis than TAG formation for maintaining membrane formation, cell growth and viability. When cells enter the stationary growth phase, phospholipid biosynthesis is decreased and the surplus of DAG and fatty acids are directed towards TAG formation leading to accumulation of this storage lipid in cytosolic LP. Similarities in the fatty acid compositions of TAG and phospholipids, but also the important role of TAG hydrolysis for sustaining the level of major yeast membrane phospholipids, support the idea of a link between TAG and phospholipid metabolism [@bb0245; @bb0250]. Identification of phospholipid:diacylglycerol acyltransferases (PDATs) refined our understanding of the close relationship between phospholipid and TAG metabolism. Previous studies demonstrated that PE is the preferred acyl-donor for the acyl-CoA independent reaction of TAG biosynthesis catalyzed by Lro1p in yeast and plants [@bb0065; @bb0070; @bb0075]. Since these data were derived from *in vitro* studies, the questions as to the relevance of the Lro1p reaction *in vivo* remained. The usage of PE as a donor of fatty acids for TAG synthesis by Lro1p was of particular interest because this phospholipid is synthesized by four different routes in the yeast (see [Introduction](#s0005){ref-type="sec"}). For this purpose, we dissected the relative contributions of the different PE biosynthetic pathways to TAG synthesis using a set of distinct yeast mutants.

To make lipid metabolic conditions for the yeast as stringent as possible, especially with respect to the requirement for PE, we cultivated cells on minimal media containing lactate as a non-fermentable carbon source. We had demonstrated before that on complex media containing lactate Psd1p became paramount as a PE synthesizing enzyme, and even exogenous supply of Etn could not restore the cellular and mitochondrial levels of PE [@bb0155]. An unexpected finding, however, was that the CDP-Etn branch of the Kennedy pathway became almost equally important as Psd1p when cells were grown on minimal lactate media (see [Table 3](#t0015){ref-type="table"}) or on complex media containing oleic acid [@bb0165]. Thus, culture conditions and especially the use of different carbon sources affect the various PE biosynthetic pathways. Notably, the growth characteristics of *psd1Δ* and *cki1Δdpl1Δeki1Δ* on lactate media are different. Whereas the mutant bearing defects in the CDP-Etn branch of PE synthesis can grow very well on minimal lactate media, *psd1Δ* requires supplementation with Etn (see [Fig. 1](#f0005){ref-type="fig"}). The reason for this growth defect might be the specific depletion of mitochondrial PE in the *psd1Δ* mutant strain.

The second striking effect observed with *cki1Δdpl1Δeki1Δ* cultivated under the given conditions was the dramatically decreased TAG level (see [Fig. 2](#f0010){ref-type="fig"}). This effect was unique among all mutant strains compromised in PE formation and surprising. We had initially speculated that lack of competition for the cellular DAG pool would lead to an increase of TAG in *cki1Δdpl1Δeki1Δ*. This assumption was in line with results obtained with mice where elimination of the CDP-Etn pathway indeed led to an increase of neutral lipid classes [@bb0255; @bb0260]. The phosphoethanolamine cytidylyltransferase (ECT)-deficient liver/hepatocytes of these mice displayed 10-fold elevated levels of TAG whereas cholesterol, cholesterol esters, DAG and free fatty acids were about 2-fold higher than controls. Our data, however, demonstrated a profound decrease of cellular TAG when PE formation *via* the CDP-Etn pathway was blunted. This discrepancy between mammalian cells and the yeast is most likely due to different efficiency of PE supply by the various PE biosynthetic pathways. Whereas in the yeast Psd1p is the major enzyme of cellular PE formation [@bb0145; @bb0155], in mammalian cells the major route of PE biosynthesis strongly depends on the type of tissue and cell [@bb0265]. It was reported that in several cell lines such as CHO cells PE was predominantly supplied by PS decarboxylation, whereas in rat liver/hepatocytes and hamster heart the CDP-Etn pathway was the major route of PE synthesis. The other marked difference is the existence of the PDAT Lro1p in yeast which has no counterpart in mammalian cells [@bb0045; @bb0060; @bb0065; @bb0070].

The third striking observation was that the total cellular level of PE is not crucial for TAG synthesis in the yeast. This can be clearly seen from the lipid profiles of mutant strains (see [Table 3](#t0015){ref-type="table"} and [Fig. 2](#f0010){ref-type="fig"}). While in *psd1∆psd2∆* and in *cki1∆dpl1∆eki1∆* cellular levels of PE were comparably low, the TAG level was dramatically affected only in *cki1∆dpl1∆eki1∆*. We assume that subcellular localization of the enzymes of the CDP-Etn pathway and Lro1p in the ER is more relevant for the observed effect than the total amount of PE in cells. This view is confirmed by the strongly decreased microsomal level of PE and the significant reduction of Lro1p activity in *cki1∆dpl1∆eki1∆* which is associated with profound reduction of TAG (see [Table 3](#t0015){ref-type="table"} and [Fig. 3](#f0015){ref-type="fig"}).

In summary, the CDP-Etn branch of the Kennedy pathway appears to fulfill two tasks in the yeast. First, it supplies mitochondria with PE which is underlined by the observation that the growth defect of *psd1∆* can be rescued by Etn (see [Fig. 1](#f0005){ref-type="fig"}). Secondly, the CDP-Etn branch appears to support TAG formation through the acyl-CoA independent pathway catalyzed by Lro1p. The dramatically reduced TAG level in *cki1∆dpl1∆eki1∆* (see [Fig. 2](#f0010){ref-type="fig"}), the reduced Lro1p activity measured *in vitro* (see [Fig. 3](#f0015){ref-type="fig"}) and the low cellular and microsomal PE content (see [Table 3](#t0015){ref-type="table"}) in this strain support this hypothesis. In summary, we demonstrate that both, subcellular localization of enzymes involved in this process in the ER and availability of PE within this compartment play an important role in the network of phospholipid and TAG metabolism.

We thank M. Connerth and R. Nebauer for providing *psd1Δ* and *cki1Δdpl1Δeki1Δ* mutant strains. This work was financially supported by the Fonds zur Förderung der wissenschaftlichen Forschung in Österreich (DK Molecular Enzymology W901-B05 and project P21429 to G. D.).

![Growth of yeast strains with defects in phosphatidylethanolamine biosynthesis depends on the carbon sources. Cell suspensions of strains listed in the figure were spotted at dilutions (1, 1/10, 1/100, 1/1000, 1/10,000) on YPD, YPLac, MMGlu and MMLac with or without 5 mM ethanolamine. Incubation was carried out at 30 °C. YPD, complex glucose media; YPLac, complex lactate media; MMGlu, minimal glucose media; MMLac, minimal lactate media; Etn, ethanolamine.](gr1){#f0005}

![Neutral lipid composition of wild type and mutants defective in either phosphatidylethanolamine or triacylglycerol biosynthesis grown to stationary phase. Amounts of triacylglycerols (black bars) and ergosteryl esters (gray bars) in μg lipid per mg protein were measured in strains as indicated. Data are mean values of 3 independent experiments with error bars indicating the standard deviation. Significance was calculated by Student\'s *t*-test (two tailed, unpaired). Values indicated by \* correspond to P \< 0.05 and were defined to be significant.](gr2){#f0010}

![Relative activities of triacylglycerol synthesizing enzymes *in vitro*. Acyl-CoA:diacylglycerol acyltransferase activity (Dga1p) (gray bars) was measured *in vitro* using total cell-free homogenate. Phospholipid:diacylglycerol acyltransferase activity (Lro1p) (black bars) was measured using 100,000 × *g* microsomes. The specific activity of Lro1p and Dga1p in wild type was set to 100%, and data for mutant strains were calculated accordingly. As negative control, phospholipid:diacylglycerol acyltransferase was measured in *lro1Δ*, and acyl-CoA:diacylglycerol acyltransferase in *dga1Δ*. Data are mean values of 3 independent experiments with error bars indicating the standard deviation. Significance was calculated by Student\'s *t*-test (two tailed, unpaired). Values indicated by \* correspond to P \< 0.05 and were defined to be significant.](gr3){#f0015}

![Gene expression levels of *LRO1*, *DGA1* and *ACT1* from wild type and strains defective in phosphatidylethanolamine and triacylglycerol biosynthesis. Strains listed in the figure were tested by RT-PCR. *ACT1* (actin) was used as a loading control and *lro1Δ* and *dga1Δ* were used as negative control for *LRO1* and *DGA1* expression.](gr4){#f0020}

![Amounts of total phospholipids from wild type and strains defective in phosphatidylethanolamine and triacylglycerol biosynthesis grown to the stationary phase. The amounts of total phospholipids in μg lipid per mg protein were measured in strains as indicated. Data are mean values of 3 independent experiments with error bars indicating the standard deviation. Significance was calculated by Student\'s *t*-test (two tailed, unpaired). Values indicated by \* correspond to P \< 0.05 and were defined to be significant.](gr5){#f0025}

###### 

Yeast strains used in this study.

  Strain              Genotype                                                                                   Source/reference
  ------------------- ------------------------------------------------------------------------------------------ ------------------
  Wild type           BY4741 *MAT***a***his3Δ1 leu2Δ0 met15Δ0 ura3Δ0*                                            Euroscarf
  *psd1Δ*             BY4741 *MAT***a***his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 psd1Δ::His3MX6*                             This study
  *psd2Δ*             BY4741 *MAT***a***his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 psd2Δ::KanMX4*                              Euroscarf
  *ale1Δ*             BY4741 *MAT***a***his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ale1Δ::KanMX4*                              Euroscarf
  *lro1Δ*             BY4741 *MAT***a***his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 lro1Δ::KanMX4*                              Euroscarf
  *dga1Δ*             BY4741 *MAT***a***his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 dga1Δ::KanMX4*                              Euroscarf
  *cki1Δdpl1Δeki1Δ*   BY4741 *MAT***a***his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cki1Δ::His3MX6 dpl1Δ::LEU2 eki1Δ::KanMX4*   This study
  *psd1Δpsd2Δ*        BY4741 *MAT***a***his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 psd1Δ::His3MX6 psd2Δ::KanMX4*               This study
  *dga1Δlro1Δ*        BY4741 *MAT***a***his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 dga1Δ::His3MX6 lro1Δ::KanMX4*               This study

###### 

Primers used for the construction of deletion strains and for RT-PCR. The underlined sequences are homologous to the *His3MX6* disruption cassette (PSD1-H1, PSD1-H2, DGA1 Del_for, DGA1 Del_rev). Amplified plasmid DNA with the primers PSD1-H1 and PSD1-H2 led to *PSD1* deletion, whereas DGA1 Del_for and Del_rev to *DGA1* deletion after homologues recombination to the target loci *YNL169c* and *YOR245c*, respectively. Lro1 FP, Lro1 RP, Dga1 FP, Dga1 RP, Act1 FP and Act1 RP were used to determine expression levels of *LRO1*, *DGA1* and *ACT1*.

  Primer         Primer sequence (5′--3′)
  -------------- ----------------------------------------------------------------------
  PSD1-H1        GCCAGTTAAGAACGCCTTGGCGCAAGGGAGGACGCTCCTC[CGGATCCCCGGGTTAATTAA]{.ul}
  PSD1-H2        CAGGTATGTGGTTCCAAGTGTTTGTCGCTCTTTGAATTTG[GAATTCGAGCTCGTTTAAAC]{.ul}
  DGA1 Del_for   ATAAGGAAACGCAGAGGCATACAGTTTGAACAGTCACATAA[CGGATCCCCGGGTTAATTAA]{.ul}
  DGA1 Del_rev   TTCCTGTAAGTTAATACTCTTACTTAAGATATACAGCCC[GAATTCGAGCTCGTTTAAAC]{.ul}
  Lro1 FP        ATGGGCACACTGTTTCGAAGAAATG
  Lro1 RP        AACAGGATGTTTGGCCTCGATATTA
  Dga1 FP        AAGAAGGAAGAAGGAAGCCCTACAG
  Dga1 RP        CCTGGTTGCGATAGTCAATAGTAGA
  Act1 FP        GGTCCCAATTGCTCGAGAGAT
  Act1 RP        GAAGTCCAAGGCGACGTAACA

###### 

Phospholipid composition of cell-free homogenate and microsomes from cells grown on minimal lactate media supplemented with 5 mM ethanolamine. CF, cellular fraction; H, cell-free homogenate; M, microsomes (100,000 × *g*); LPL, lysophospholipids; PI, phosphatidylinositol; PS, phosphatidylserine; PE, phosphatidylethanolamine; PC, phosphatidylcholine; CL, cardiolipin; DMPE, dimethylphosphatidylethanolamine; PA, phosphatidic acid. Mean values of at least three measurements and standard deviations are shown.

  Strain              Phospholipids in cell-free homogenate and microsomes (mol%)                                                                                                          
  ------------------- ------------------------------------------------------------- -------------- -------------- -------------- -------------- -------------- ------------- ------------- -------------
  Wild type           H                                                             2.35 ± 1.78    11.40 ± 2.65   5.09 ± 1.57    50.95 ± 4.58   24.95 ± 2.35   3.73 ± 1.46   0.39 ± 0.54   1.14 ± 0.95
  M                   1.41 ± 0.43                                                   9.91 ± 0.82    6.30 ± 0.96    58.11 ± 2.02   20.66 ± 2.23   1.45 ± 0.30    0.16 ± 0.19   2.01 ± 0.67   
  *psd1Δ*             H                                                             0.73 ± 0.52    11.87 ± 2.32   6.97 ± 1.17    58.83 ± 3.05   18.65 ± 1.03   2.12 ± 0.60   0.24 ± 0.26   0.59 ± 0.26
  M                   1.72 ± 0.19                                                   10.40 ± 2.24   6.90 ± 1.37    57.23 ± 4.38   20.50 ± 1.61   1.14 ± 0.24    0.67 ± 0.30   1.44 ± 0.56   
  *psd2Δ*             H                                                             0.20 ± 0.34    8.55 ± 0.72    6.88 ± 2.16    59.73 ± 2.92   21.44 ± 4.31   2.64 ± 1.78   0.04 ± 0.07   0.52 ± 0.54
  M                   1.35 ± 0.13                                                   10.56 ± 0.55   6.12 ± 0.71    57.01 ± 1.64   21.10 ± 2.29   1.79 ± 0.25    0.42 ± 0.16   1.65 ± 0.88   
  *psd1Δpsd2Δ*        H                                                             0.96 ± 0.73    5.12 ± 3.27    9.01 ± 2.36    66.74 ± 5.86   14.63 ± 1.05   1.97 ± 0.71   0.89 ± 1.02   0.69 ± 0.47
  M                   1.85 ± 0.52                                                   8.80 ± 2.23    9.71 ± 2.25    60.67 ± 3.90   16.01 ± 0.43   1.19 ± 0.14    0.39 ± 0.15   1.38 ± 0.40   
  *ale1Δ*             H                                                             0.52 ± 0.45    7.35 ± 3.76    6.13 ± 2.66    51.71 ± 4.72   30.32 ± 2.35   2.55 ± 1.01   0.38 ± 0.66   1.06 ± 0.68
  M                   1.61 ± 0.32                                                   10.52 ± 1.42   5.10 ± 0.36    56.94 ± 2.67   21.58 ± 2.91   1.74 ± 0.33    0.65 ± 0.22   1.86 ± 0.54   
  *cki1Δdpl1Δeki1Δ*   H                                                             0.77 ± 0.88    11.56 ± 3.66   5.34 ± 1.57    59.22 ± 4.57   16.93 ± 1.12   4.40 ± 0.68   0.20 ± 0.32   1.57 ± 0.58
  M                   2.31 ± 1.12                                                   10.80 ± 4.15   5.14 ± 1.36    65.62 ± 5.18   12.15 ± 0.24   1.67 ± 0.39    0.56 ± 0.41   1.75 ± 0.98   
